The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found.
Oct 25, 2018
0
48
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., ...
Jun 22, 2018
1
53
A new report generated by a team at Johns Hopkins Bloomberg School of Public Health suggests we might be fearing the wrong types of viruses. Instead of worrying about Ebola or Zika, the report contends, we should be worrying ...
A Yale-led research team developed a new RNA therapy, delivered through the nose, to treat mice infected with West Nile Virus. The innovative approach reduced the virus in the brain, allowing the immune system to destroy ...
Mar 29, 2018
0
95
University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.
Mar 7, 2018
0
42
New research shows that a new class of antiviral drugs works by causing the virus' replication machinery to pause and backtrack, preventing the virus from efficiently replicating. This discovery, made possible by a high-throughput ...
Oct 24, 2017
0
20
A discovery by Melbourne researchers has solved a longstanding mystery of how viruses trigger protective immunity within our body.
Sep 12, 2017
0
138
Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found. The research team, which included investigators ...
Aug 2, 2017
0
19
The billion-year-old primordial system by which early life forms protected themselves against viral infection can still be found in human cells, despite the presence of the much more sophisticated and powerful defense system ...
Jun 28, 2017
0
11
A combination of two cancer drugs inhibited both dengue and Ebola virus infections in mice in a study led by Stanford University School of Medicine researchers, despite the fact that these two viruses are vastly different ...
Feb 27, 2017
0
54
